Education
About Us
Working with TipRanks
Follow Us
Arrowhead Pharmaceuticals (GB:0HI3)
LSE:0HI3
0HI3 Analyst Ratings
Moderate Buy
6 Buy
5 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0HI3 Stock 12 Month Forecast
Average Price Target
$35.75
▼(-2.22% Downside)
| Highest Price Target$80.00 | Average Price Target$35.75 | Lowest Price Target$12.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$80
Buy
118.82%
Upside
Reiterated
10/10/25
RBC Capital
―
Buy
―
Reiterated
10/08/25
Bank of America Securities
$42
Buy
14.88%
Upside
Reiterated
10/03/25
Piper Sandler
$45
Buy
23.09%
Upside
Reiterated
09/23/25
Leerink Partners
$21→$23
Hold
-37.09%
Downside
Reiterated
09/04/25
Citi
$27.8→$17
Hold
-53.50%
Downside
Reiterated
09/03/25
Bernstein
―
Hold
―
Reiterated
08/22/25
Morgan Stanley
$29
Hold
-20.68%
Downside
Reiterated
08/08/25
TD Cowen
―
Buy
―
Reiterated
08/07/25
UBS
$63→$12
Hold
-67.18%
Downside
Downgraded
07/21/25
Cantor Fitzgerald
―
Buy
―
Reiterated
05/13/25
Goldman Sachs
$26
Hold
-28.88%
Downside
Reiterated
03/10/25
Chardan Capital
$60
Buy
64.11%
Upside
Reiterated
02/11/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$80
Buy
118.82%
Upside
Reiterated
10/10/25
RBC Capital
―
Buy
―
Reiterated
10/08/25
Bank of America Securities
$42
Buy
14.88%
Upside
Reiterated
10/03/25
Piper Sandler
$45
Buy
23.09%
Upside
Reiterated
09/23/25
Leerink Partners
$21→$23
Hold
-37.09%
Downside
Reiterated
09/04/25
Citi
$27.8→$17
Hold
-53.50%
Downside
Reiterated
09/03/25
Bernstein
―
Hold
―
Reiterated
08/22/25
Morgan Stanley
$29
Hold
-20.68%
Downside
Reiterated
08/08/25
TD Cowen
―
Buy
―
Reiterated
08/07/25
UBS
$63→$12
Hold
-67.18%
Downside
Downgraded
07/21/25
Cantor Fitzgerald
―
Buy
―
Reiterated
05/13/25
Goldman Sachs
$26
Hold
-28.88%
Downside
Reiterated
03/10/25
Chardan Capital
$60
Buy
64.11%
Upside
Reiterated
02/11/25
Best Analysts Covering Arrowhead Pharmaceuticals
1 Month
xxx
Success Rate
15/25 ratings generated profit
Average Return
+2.27%
reiterated a xxx
rating 21 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 60.00% of your transactions generating a profit, with an average return of +2.27% per trade.
3 Months
xxx
Success Rate
14/27 ratings generated profit
Average Return
+13.13%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 51.85% of your transactions generating a profit, with an average return of +13.13% per trade.
1 Year
Success Rate
20/37 ratings generated profit
Average Return
+27.84%
reiterated a buy rating 8 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 54.05% of your transactions generating a profit, with an average return of +27.84% per trade.
2 Years
xxx
Success Rate
19/27 ratings generated profit
Average Return
+43.64%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.37% of your transactions generating a profit, with an average return of +43.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0HI3 Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
7
8
9
9
9
Buy
2
3
2
5
6
Hold
12
15
19
19
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
21
26
30
33
29
Each month's total comprises the sum of three months' worth of ratings.
0HI3 Financial Forecast
0HI3 Stock Forecast FAQ
What is GB:0HI3’s average 12-month price target, according to analysts?
Based on analyst ratings, Arrowhead Pharmaceuticals’s 12-month average price target is 35.75.
What is GB:0HI3’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0HI3, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Arrowhead Pharmaceuticals a Buy, Sell or Hold?
Arrowhead Pharmaceuticals has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.
What is Arrowhead Pharmaceuticals’s share price target?
The average share price target for Arrowhead Pharmaceuticals is 35.75. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $80.00 ,and the lowest forecast is $12.00. The average share price target represents -2.22% Decrease from the current price of $36.56.
The highest analyst share price target is $80.00 ,and the lowest forecast is $12.00. The average share price target represents -2.22% Decrease from the current price of $36.56.
What do analysts say about Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of Arrowhead Pharmaceuticals?
To buy shares of GB:0HI3, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.